Favorable News Coverage Somewhat Unlikely to Impact LifePoint Health (NASDAQ:LPNT) Stock Price

Media stories about LifePoint Health (NASDAQ:LPNT) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. LifePoint Health earned a media sentiment score of 0.43 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.9944288697398 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

LifePoint Health (NASDAQ LPNT) traded up $1.25 during midday trading on Friday, reaching $49.60. The company’s stock had a trading volume of 744,229 shares, compared to its average volume of 512,134. LifePoint Health has a one year low of $42.50 and a one year high of $70.95. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. The company has a market capitalization of $1,960.00, a price-to-earnings ratio of 11.75, a P/E/G ratio of 1.14 and a beta of 0.67.

LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter last year, the business earned $0.94 earnings per share. LifePoint Health’s quarterly revenue was down .7% on a year-over-year basis. analysts forecast that LifePoint Health will post 3.64 earnings per share for the current fiscal year.

LifePoint Health declared that its board has authorized a stock buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board of directors believes its shares are undervalued.

LPNT has been the topic of several research analyst reports. Credit Suisse Group initiated coverage on LifePoint Health in a research report on Thursday, November 2nd. They set a “neutral” rating and a $54.00 price target on the stock. Leerink Swann reiterated an “outperform” rating and set a $58.00 price target (down from $74.00) on shares of LifePoint Health in a research report on Tuesday, October 31st. They noted that the move was a valuation call. BidaskClub raised LifePoint Health from a “strong sell” rating to a “sell” rating in a research note on Friday, December 15th. SunTrust Banks set a $60.00 price objective on LifePoint Health and gave the stock a “hold” rating in a research note on Thursday, October 12th. Finally, Raymond James Financial reissued a “market perform” rating on shares of LifePoint Health in a research note on Monday, October 30th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $59.14.

In other news, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total value of $174,760.11. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 8.76% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/01/13/positive-news-coverage-somewhat-unlikely-to-affect-lifepoint-health-lpnt-share-price.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Insider Buying and Selling by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply